Kura Oncology, Inc. (KURA)
9.35
+0.14
(+1.52%)
USD |
NASDAQ |
Jan 14, 10:24
Kura Oncology Market Cap: 813.61M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AIM ImmunoTech, Inc. | 3.618M |
| Perspective Therapeutics, Inc. | 195.88M |
| Protalix Biotherapeutics, Inc. | 159.23M |
| Electromed, Inc. | 230.28M |
| Armata Pharmaceuticals, Inc. | 211.08M |
Market Cap Related Metrics
| PS Ratio | 7.859 |
| PEG Ratio | -0.7287 |
| Price to Book Value | 3.355 |
| Price to Free Cash Flow | 9.838 |
| Price | 9.35 |
| Earnings Yield | -26.50% |
| PEGY Ratio | -0.7287 |